Long-term blood-thinner therapy registry for heart disease
Part of Heart & circulation, Pain clinical trials.
This study follows people with known coronary artery disease to understand how long-term “blood thinner” treatments are used and how they affect health over time. You may be asked to share medical information and come in for follow-up to help researchers compare outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed coronary artery disease (for example, prior heart attack or a heart procedure, or evidence on a scan).
- You can and are willing to sign informed consent to take part.
- Your last “acute coronary syndrome” event (a recent heart circulation emergency) was more than 12 months ago.
- You have not had a stroke in the last 6 months.
- You do not have very severe end-stage heart failure (NYHA class IV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This study creates a registry to track long-term outcomes for people with chronic coronary syndrome (blockages that reduce blood flow to the heart) who are getting a planned stent. It will use a blood test to see how your body responds to anti-clotting medications.
This study looks at the safest way to handle your blood thinners when you have a colonoscopy. It is for people with stable heart or blood vessel disease who take two blood thinners and need a routine screening or follow-up colonoscopy.
This study looks at how anti-platelet medicines like aspirin and clopidogrel work in people with hardened arteries (atherosclerosis) or peripheral artery disease (PAD). The goal is to understand how these drugs affect your body's clotting system.
This registry collects information from people with coronary (heart) artery disease who already had platelet-related blood tests as part of usual care. The goal is to better understand how platelet responses relate to treatment and outcomes, which may help future care.
Hear when a new Peripheral Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.